pharmacology
Meet the alpacas that are helping researchers who study autism, Alzheimer’s and cancer
Aug. 13, 2019—Alpacas aren’t the typical animals that drivers spot as they wind their way through rural Tennessee, but there’s a happy herd of them outside Waverly, where they eat the finest pellets, walk up and down a scenic hill and potentially save lives. They’re owned by a team of Vanderbilt University researchers looking to harness their...
Ancora announces major funding awards to support Vanderbilt drug discovery research
Nov. 26, 2018—Ancora Innovation, LLC, the new collaboration between Vanderbilt and Deerfield Management established earlier this year, has completed its inaugural proposal review process and announced two projects selected for funding.
New faculty: Lisa Monteggia
Nov. 12, 2018—Lisa Monteggia is professor of pharmacology and Barlow Family Director of the Vanderbilt Brain Institute.
Three VU doctoral students receive 2018 Gilliam Fellowships for Advanced Study
Aug. 1, 2018—The Howard Hughes Medical Institute has awarded 2018 Gilliam Fellowships for Advanced Study—created to ensure that a diverse and highly trained workforce is prepared to assume leadership roles in the sciences—to three Vanderbilt University doctoral students and their advisers.
$8.1 million grant funds new center to research highly aggressive form of lung cancer
Jun. 8, 2018—A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.
Vanderbilt earns top rankings, including a No. 1, for successful minority recruitment in master’s and Ph.D. programs
Dec. 12, 2016—"Diverse: Issues In Higher Education" has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences.
New faculty: David Sweatt studies how brain chemistry affects learning and memory
Oct. 13, 2016—Homecoming came early this year for Vanderbilt alumnus David Sweatt, who joined the faculty as chair of Pharmacology this summer, 30 years after receiving his Ph.D. from the department he now leads.
Basic science, extraordinary impact
Oct. 6, 2016—The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.
New center will examine addiction at molecular level, develop treatments
Aug. 17, 2016—Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.
Davies lands Pharmacology teaching award
May. 26, 2016—Sean Davies, Ph.D., associate professor of Pharmacology, was recognized as Pharmacology “Teacher of the Year” during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall.
Sweatt named chair of Department of Pharmacology
Mar. 10, 2016—J. David Sweatt, Ph.D., the Evelyn F. McKnight Endowed Chair of the Department of Neurobiology, director of the Civitan International Research Center, and director of the McKnight Brain Institute at the University of Alabama, Birmingham, has been named chair of Vanderbilt’s Department of Pharmacology.
Study reveals possible ‘dimmer switch’ drug for Rett syndrome
Mar. 3, 2016—Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.